CRYOPORT INC. news, videos and press releases
For more news please use our advanced search feature.
CRYOPORT INC. - More news...
CRYOPORT INC. - More news...
- Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies
- Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
- Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")
- Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe
- Cryoport Reports Third Quarter 2024 Financial Results
- Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024
- Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
- TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
- Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus
- SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
- The Schall Law Firm Begins Investigation Into Claims Against Cryoport Inc And Encourages Its Shareholders To Reach Out
- The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Its Shareholders To Get In Touch
- Cryoport Reports Second Quarter 2024 Financial Results
- Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes
- Cryoport Incorporated Stockholders Are Invited By The Schall Law Firm To Reach Out Amidst The Initiation Of An Allegations Investigation
- Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024
- Cryoport Inc Shareholders Are Urged To Contact As The Schall Law Firm Initiates An Investigation Into Claims
- The Schall Law Firm Is Examining Allegations Against Cryoport Inc And Encourages Its Shareholders To Establish Communication
- The Schall Law Firm Is Investigating Claims Against Cryoport Inc And Urges Its Shareholders To Make Contact
- The Schall Law Firm Is Examining Allegations Against Cryoport Inc And Encourages Its Shareholders To Establish Communication
- Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm
- CYRX IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm
- Cryoport Reports First Quarter 2024 Financial Results
- Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024
- Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
- Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
- Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services
- Cryoport Reports Third Quarter 2023 Financial Results
